After decades of decline in the developed world, tuberculosis (TB) is back on the rise, and increasingly resistant to our best antibiotics. The World Health Organization (WHO) is calling it a public health crisis – but help may be on the way to fight the world's top infectious killer . An international team of researchers has studied three promising experimental antibiotic compounds – ecumicin, ilamycins, and cyclomarins – to determine how they take down Mycobacterium tuberculosis , the

Tag-uri: Medicamente